April 12, 2021 | Leadership
Matthew Gantz is President and Chief Executive Officer of Castle Creek Biosciences, Inc., and a member of the company’s Board of Directors. An accomplished life sciences executive with more than 25 years of experience in the specialty biopharmaceutical and medical device industries, Mr. Gantz previously served as Chief Executive Officer of OxThera AB. Prior to […]
Read MoreFebruary 08, 2023 | Leadership
Christopher Ballas is Chief Technology Officer at Castle Creek Biosciences, Inc. He has over 25 years of experience with cell and gene therapies in academic and industry roles covering research, development, testing, and manufacturing of viral vectors and cell therapies. Dr. Ballas recently was the Sr. Vice President of Manufacturing for Innovative Cellular Therapeutics. Prior […]
Read MoreOctober 12, 2021 | Leadership
Mike Maurer is Vice President of Manufacturing of Castle Creek Biosciences, Inc. Recognized as a skillful and proven leader in manufacturing, he brings more than 30 years of experience spanning the biopharma, vaccine and cell & gene therapy industries. Mr. Maurer spent most of his career at GlaxoSmithKline (GSK) and Merck. His experience with GSK […]
Read MoreJuly 05, 2020 | Leadership
Robin Blumenthal is the Associate Vice President of Clinical Operations at Castle Creek Biosciences, Inc. Previously she held key clinical operations positions at Menlo Therapeutics, Pfizer and Anacor. Her extensive background in immunology and clinical operations has consistently contributed to the successful development and management of complex clinical programs. Dr. Blumenthal holds a Ph.D. in […]
Read MoreMarch 30, 2023 | Leadership
Sreeti Choudhury is an Associate Vice President of Analytical Sciences and Quality Control (QC) Operations at Castle Creek Biosciences, Inc. She has over 20 years of experience in managing analytical development and QC testing from early- to late-phase programs, global regulatory filing, including lipid-based targeted chemotherapy, vaccines, cell therapies and gene therapies. Prior to joining […]
Read MoreJuly 30, 2021 | Leadership
January Salas-McKee is the Associate Vice President of Process Sciences at Castle Creek Biosciences, Inc. She is responsible for optimization and refinement of manufacturing processes and analytical assays, technology transfer, process and product characterization, and support-generating regulatory dossier. Dr. Salas-McKee has more than 13 years of experience in process and analytical development for cell and […]
Read MoreMarch 30, 2023 | Leadership
Savita Mehra is Vice President of Quality Assurance at Castle Creek Biosciences, Inc. She has over 30 years of experience in developing, implementing, and successfully sustaining quality management systems in various manufacturing sectors, including gene therapy and biologics, and assuring compliance to regulatory requirements. Ms. Mehra has been a liaison for the FDA, EU and […]
Read MoreJune 30, 2022 | Leadership
Matt Crabtree is the Senior Director of Finance and Corporate Controller of Castle Creek Biosciences, Inc. He is responsible for financial accounting and reporting, budgeting, treasury management, tax, and information technology. Mr. Crabtree began his career at KPMG and has 17 years of financial expertise. Previously he was a Senior Vice President, Corporate Controller for […]
Read More